Current Report · Items 2.02, 9.01 · 8-K

Phibro Animal Health Corporation

PAHCNASDAQEQUITYCurrent

Results of Operations and Financial Condition

Filed Aug 26, 2026Accepted Aug 26, 2026, 4:30 PM EDTCIK 1069899Accession 0001104659-26-101531

Company context

Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit www.pahc.com.

Current securities

PAHCNASDAQ · EQUITY · Current

Recent company filings

Disclosure sections

Items 2.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On August 26, 2026, Phibro Animal Health Corporation issued a press release announcing its operating results for the fourth quarter and fiscal year ended June 30, 2026 and its financial guidance for the fiscal year ending June 30, 2027. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this report, including the exhibit attached hereto, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of, or otherwise regarded as filed under, the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Filed exhibits (1)

EX-99.1 (by filename) pahc-20260826xex99d1.htm

EX-99.1 2 pahc-20260826xex99d1.htm EX-99.1 Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance TEANECK, N.J., August 26, 2026 (Business Wire) - Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2026 and provided its financial guidance for the fiscal year ending June 30, 2027. Highlights for the three months ended June 30, 2026 (compared to the three months ended June 30, 2025) -Net sales of $396.7 million, an increase of $18.1 million, or 5% -Net income of $21.7 million, an increase of $4.5 million, or 26% -Diluted earnings per share of $0.53, an increase of $0.11, or 26% -Adjusted EBITDA of $64.2 million, an increase of $14.3 million, or 29% -Adjusted net income of $35.0 million, an increase of $9.4 million, or 37% -Adjusted diluted EPS of $0.85, an increase of $0.22, or 35% Highlights for the year ended June 30, 2026 (compared to the year ended June 30, 2025) - Net sales of $1,518.1 million, an increase of $221.9 million, or 17% - Net income of $99.7 million, a…

Open exhibit ↗